公开(公告)号：US20160129055A1

公开(公告)日：2016-05-12

申请号：US14935298

申请日：2015-11-06

申请人： Jens KILDSGAARD ,  Thomas Dyrmann LESER ,  Thomas GUNNARSSON ,  Mette WEISE ,  Ditte Marie FOLKENBERG ,  Thomas JANZEN ,  Benedicte FLAMBARD

发明人： Jens KILDSGAARD ,  Thomas Dyrmann LESER ,  Thomas GUNNARSSON ,  Mette WEISE ,  Ditte Marie FOLKENBERG ,  Thomas JANZEN ,  Benedicte FLAMBARD

IPC分类号： A61K35/745

CPC分类号： A61K35/745 ,  A23L33/135 ,  C12P19/04 ,  C12R1/01 ,  Y02A50/473 ,  Y02A50/481

摘要： Regarding Deposited Microbial Organisms [EXPERT SOLUTION]For all deposited microbial organisms mentioned in the present patent application and which not are in collections open to the public the so-called expert solution is requested.In respect to those designations in which a European Patent is sought a sample of the deposited microorganism will be made available until the publication of the mention of the grant of the European patent or until the date on which application has been refused or withdrawn or is deemed to be withdrawn, only by the issue of such a sample to an expert nominated by the person requesting the sample, and approved either i) by the Applicant and/or ii) by the European Patent Office, whichever applies.

摘要翻译： 关于沉积的微生物生物体[专家解决方案]对于本专利申请中提及的所有沉积的微生物，而不是向公众开放的收集所要求的专家解决方案。 对于寻求欧洲专利的指定，存放微生物的样本将提供直到提及欧洲专利的授予或直到申请被拒绝或撤回或被认为的日期 只有通过向提出样本的人提名的专家发出这样的样本，并且由申请人和/或ii）由欧洲专利局批准，以适用者为准。

公开(公告)号：US20110177034A1

公开(公告)日：2011-07-21

申请号：US13002968

申请日：2009-07-06

申请人： Jens Kildsgaard ,  Thomas Dyrmann Leser ,  Thomas Gunnarsson ,  Mette Weise ,  Ditte Marie Folkenberg ,  Thomas Janzen ,  Benedicte Flambard

发明人： Jens Kildsgaard ,  Thomas Dyrmann Leser ,  Thomas Gunnarsson ,  Mette Weise ,  Ditte Marie Folkenberg ,  Thomas Janzen ,  Benedicte Flambard

IPC分类号： A61K35/74 ,  C12N1/20 ,  C08B37/00 ,  A61P29/00 ,  A61P1/00

CPC分类号： A61K35/745 ,  A23L33/135 ,  C12P19/04 ,  C12R1/01 ,  Y02A50/473 ,  Y02A50/481

摘要： The invention relates to novel, probiotic, anti-inflammatory strains of Bifidobacterium longum, their use for treatment of diseases, and for preparation of human or pet food or pharmaceutical compositions. The strains produce high amounts of exopolysaccharides with a high content of mannose- and glucose residues. Accordingly, the invention also relates to a bacterial polysaccharide composition obtained from the strains, their use for treatment of diseases, and pharmaceutical compositions comprising such polysaccharides.

摘要翻译： 本发明涉及长双歧杆菌的新型益生菌抗炎菌株，其用于治疗疾病的用途，以及人或宠物食品或药物组合物的制备。 菌株产生大量甘露糖和葡萄糖残留量的胞外多糖。 因此，本发明还涉及从菌株获得的细菌多糖组合物，其用于治疗疾病的用途，以及包含这种多糖的药物组合物。